Immunological Barriers to Stem Cell Therapy in the Central Nervous System
Joint Authors
Kirk, Mark D.
Tullis, Gregory E.
Spears, Kathleen
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-08-05
Country of Publication
Egypt
No. of Pages
12
Abstract EN
The central nervous system is vulnerable to many neurodegenerative disorders such as Alzheimer’s disease that result in the extensive loss of neuronal cells.
Stem cells have the ability to differentiate into many types of cells, which make them ideal for treating such disorders.
Although stem cell therapy has shown some promising results in animal models for many brain disorders it has yet to translate into the clinic.
A major hurdle to the translation of stem cell therapy into the clinic is the immune response faced by stem cell transplants.
Here, we focus on immunological and related hurdles to stem cell therapies for central nervous system disorders.
American Psychological Association (APA)
Tullis, Gregory E.& Spears, Kathleen& Kirk, Mark D.. 2014. Immunological Barriers to Stem Cell Therapy in the Central Nervous System. Stem Cells International،Vol. 2014, no. 2014, pp.1-12.
https://search.emarefa.net/detail/BIM-1047523
Modern Language Association (MLA)
Tullis, Gregory E.…[et al.]. Immunological Barriers to Stem Cell Therapy in the Central Nervous System. Stem Cells International No. 2014 (2014), pp.1-12.
https://search.emarefa.net/detail/BIM-1047523
American Medical Association (AMA)
Tullis, Gregory E.& Spears, Kathleen& Kirk, Mark D.. Immunological Barriers to Stem Cell Therapy in the Central Nervous System. Stem Cells International. 2014. Vol. 2014, no. 2014, pp.1-12.
https://search.emarefa.net/detail/BIM-1047523
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1047523